Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPID: Iodopovidone Pleurodesis via IPC
NCT03325192Terminated
- Sponsor
- University of Pennsylvania
- Start
- Dec 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of povidone-iodine in malignant pleural effusion (MPE) (2 arms), sponsored by University of Pennsylvania. Primary endpoint: Time to catheter removal at 90 days. Started Dec 2017; status: terminated.
02
Drugs
povidone-iodine
03
Conditions
malignant pleural effusion (MPE)
Beyond the preview
Go deeper on NCT03325192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03325192.